NERVGEN PHARMA CORP. Total Liabilities

by

Quick Answer

NERVGEN PHARMA CORP. reported total liabilities of C$19.73 million for fiscal year 2025 (IFRS, Form 20-F).

Reported under IFRS (SEC Form 20-F). Figures are shown in USD where the company provided them, otherwise in its reporting currency — each value exactly as filed with the SEC, not converted.

NERVGEN PHARMA CORP. Total Liabilities — Annual History

Fiscal Year Total Liabilities YoY Change
2025 C$19.73M +16.7%
2024 C$16.91M —
  • NERVGEN PHARMA CORP.’s total liabilities rose 16.7% year over year.
  • The most recent figure is from NERVGEN PHARMA CORP.’s fiscal year 2025 annual report (Form 20-F), filed March 31, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 19, 2026.

Last verified:

Leave a Comment